학술논문
First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study
Document Type
Article
Author
Source
In The Breast December 2020 54:256-263
Subject
Language
ISSN
0960-9776